Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Silence Therapeutics (SLN) Asset Utilization Ratio (2021 - 2025)

Silence Therapeutics' Asset Utilization Ratio history spans 5 years, with the latest figure at 0.0 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 95.45% to 0.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0, a 95.45% decrease, with the full-year FY2025 number at 0.0, down 98.75% from a year prior.
  • Asset Utilization Ratio hit 0.0 in Q4 2025 for Silence Therapeutics, down from 0.17 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for SLN hit a ceiling of 18081.7 in Q2 2021 and a floor of 0.0 in Q4 2025.
  • Historically, Asset Utilization Ratio has averaged 3094.88 across 5 years, with a median of 0.07 in 2023.
  • Biggest five-year swings in Asset Utilization Ratio: crashed 100.0% in 2022 and later skyrocketed 520.78% in 2025.
  • Tracing SLN's Asset Utilization Ratio over 5 years: stood at 14388.48 in 2021, then crashed by 100.0% to 0.04 in 2022, then skyrocketed by 49.6% to 0.07 in 2023, then increased by 28.37% to 0.08 in 2024, then plummeted by 95.45% to 0.0 in 2025.
  • Business Quant data shows Asset Utilization Ratio for SLN at 0.0 in Q4 2025, 0.17 in Q3 2025, and 0.15 in Q2 2025.